Davenport & CO LLC Astrazeneca PLC Transaction History
Davenport & CO LLC
- $16.7 Billion
- Q4 2024
A detailed history of Davenport & CO LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Davenport & CO LLC holds 14,017 shares of AZN stock, worth $968,014. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,017
Previous 14,535
3.56%
Holding current value
$968,014
Previous $1.13 Million
18.9%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding AZN
# of Institutions
1,340Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.34 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.9 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.57 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.54 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.32 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $214B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...